MedTrace Logo

Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer

NCT01196403 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2011-04-01

No results posted yet for this study

Summary

RATIONALE: Minimal-access surgery uses a smaller opening in the body to remove the tumor than is used in standard surgery. It is not yet known whether minimal-access surgery to remove the bladder is more effective than standard surgery to remove the bladder in treating patients with bladder cancer.

PURPOSE: This randomized phase II trial is studying standard surgery to see how well it works compared with minimal-access surgery in treating patients with bladder cancer.

Conditions

Interventions

OTHER

questionnaire administration

PROCEDURE

quality-of-life assessment

PROCEDURE

robot-assisted laparoscopic surgery

PROCEDURE

therapeutic conventional surgery

PROCEDURE

therapeutic laparoscopic surgery

Sponsors & Collaborators

  • Wales Cancer Trials Unit

    lead OTHER

Principal Investigators

  • John Kelly, MD · University College London Hospitals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01196403 on ClinicalTrials.gov